Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for PONV after gynecologic laparoscopy
ChiCTR2300076452Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative nausea and vomiting (PONV) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Incidence of PONV within 24 hours after surgery. Started Oct 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2300076452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076452.